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ABSTRACT 
 
Pleurotus giganteus mushroom is used for culinary purposes by the indigenous people 
(Orang Asli) in Malaysia for food. The present study was undertaken to extract and 
profile the bioactive metabolites in the fruiting bodies of the cultivated mushroom. 
Various chemical solvents were used in this investigation because different compounds 
were extracted by different solvents based on the solvent’s polarity. The solvents 
employed were methanol, hexane, ethyl acetate, distilled water and butanol. The  ethyl 
acetate and hexane extracts  were then subjected to  flash column chromatography with 
stepwise addition of hexane and acetone. The identification of compounds in the sub-
fractions from ethyl acetate and hexane extracts were done using  GC-MS and LC-
MS/MS analyses. Twenty seven secondary metabolites namely fatty acids such as pal-
mitic acid and oleic acid; fatty acid methyl esters such as methyl linoleate; phenolics 
such as caffeic acid and cinnamic acid; sterols such as ergosterol and neoergosterol; 
organic acids such as succinic acid and alkaloids such as N-acetylphenylethylamine 
were identified. Extraction of the flavour components (essential oil) was also 
performed. Benzyl alcohol was identified to be present in the essential oil. To our 
knowledge this is the first report of chemical components from the fruiting bodies of 
Pleurotus giganteus. 
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ABSTRAK 
Cendawan Pleurotus giganteus digunakan oleh orang asli di Malaysia sebagai makanan. 
Kajian ini telah dijalankan untuk mengekstrak dan memprofilkan metabolit aktif da-
ripada janabuah cendawan ini. Pelbagai pelarut kimia pengekstrakan telah digunakan 
dalam penyiasatan ini kerana metabolit yang berlainan telah diekstrak berdasarkan  
kepolaran pelarut tersebut.  Pelarut yang digunakkan adalah metanol,heksana, etil asetat, 
air suling  dan butanol. Ekstrak etil asetat dan heksana difraksikan menggunakan kaedah 
kromatografi kilat dengan penambahan heksana dan aseton secara berperingkat. Kom-
ponen-komponen dalam sub-fraksi etil asetat dan heksana telah dikenalpasti dengan 
menggunakan analisis KG-SJ dan KC-SJSJ. Dua puluh tujuh metabolit yang terdiri da-
ripada asid lemak seperti asid palmitik dan oleik; ester metil asid lemak  seperti metil 
linoleat; sebalian fenolik seperti asid kafeik dan  asid sinamik; sebatian sterol seperti 
ergosterol dan neoergosterol; asid organik seperti asid suksinik dan alkaloid seperti aset-
ilfemiletilamina telah dikeanlpasti. Pengekstrakan komponen perisa (minyak pati) juga 
dilaksanakan. Sebatian seperti benzyl alkohol telah dikenalpasti dalam minyak pati ini. 
Ini adalah laporan pertama tentang komponen-komponen bioaktif daripada janabuah 
Pleurotus giganteus. 
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CHAPTER 1 
INTRODUCTION 
 
In recent times consumption of mushroom species has greatly increased. This is due to 
continuous developments in cultivation, harvest, postharvest, processing and storage 
treatments, which facilitates the consumption throughout the year. Besides the nutri-
tional properties, mushrooms have been demonstrated to possess activities that contrib-
ute to health (Palacios et al., 2011). For millennia, humankind has valued mushrooms as 
an important edible and medical resource. Medicinal mushrooms have a long history of 
use in folk medicine. The use of mushroom - based medicines for healing is as ancient 
and universal as medicine itself. Until the dawn of this century, natural products from 
mushrooms have served as the mainstay of all medicines world-wide. Although herbal-
ism has declined in the west, it continues to exist throughout the developing world. 
Over 70% of the world population still relies on herbal remedies for their health care 
needs.  In particular, mushrooms that are useful against cancers of the stomach, esopha-
gus and lungs are known in China, Russia, Japan, Korea, America and Canada (Wasser , 
2002). There are about 200 species of mushrooms that have been found to markedly 
inhibit the growth of different kinds of tumors. Hitherto, several antitumor polysaccha-
rides such as hetero-beta-glucans and their protein complexes (e.g., xyloglucans and 
acidic beta-glucan-containing uronic acid), dietary fibers, lectins, and terpenoids have 
been isolated from medicinal mushrooms (Wasser, 2002). Moreover, in Japan, Russia, 
China, and America several different polysaccharide antitumor agents have been devel-
oped from the fruiting body, mycelia, and culture medium of various medicinal mush-
rooms such as Lentinula edodes, Ganoderma lucidum, Schizophyllum commune, 
Trametes versicolor, Inonotus obliqutus, and Flammulina velutipes (Wasser , 2002). 
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The use of mushrooms, past and present, and practices, represent an important 
cultural heritage as they have been used since times immemorial as food and medicine 
according to traditional ecological knowledge transmitted along generations. Mush-
rooms have long been valued as highly tasty/nutritional foods. In some fields, including 
the food and pharmaceutical industries, mushrooms are an important and valued com-
modity (Pereira et al., 2011). In 2004, the estimated value of wild edible mushroom 
gathering was $2 billion US dollars. Therefore, their chemical and biological character-
istics attract significant interest as they are natural bioreactors for the production of 
compounds with human interest (Pereira et al., 2011). 
Mushrooms accumulate a variety of bioactive metabolites (e.g. phenolic com-
pounds, polyketides, terpenes, steroids, and polysaccharides) with immunomodulatory, 
cardiovascular, liver protective, anti-fibrotic, anti-inflammatory, anti-diabetic, anti-viral, 
antimicrobial activities, and antitumor properties (Pereira et al., 2011). Purified bioac-
tive compounds derived from medicinal mushrooms are potentially important new 
source of natural antioxidants that positively influence oxidative stress related diseases 
such as cancer (Pereira et al., 2011). Thus, they might be used directly in diet and pro-
mote health, taking advantage of the additive and synergistic effects of all the bioactive 
compounds present (Reis et al., 2011). 
Mushrooms have also become one of the most desirable food in oriental cuisine 
because of their low caloric value, characteristic smell, taste and texture. Thus, mush-
rooms are considered as highly valuable bio-engineering resources for development of 
food material (functional foods as well as for use of starting material in the production 
of drugs (Mizuno, 1999). Functional compounds in mushrooms have recently been 
highlighted as they are able to lower cholesterolemia, modulate the immune system and 
inhibit tumoral growth (Zhang et al., 2001). 
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Many species of wild mushrooms such as Pleurotus porrigens (angel’s wings), 
Schizophyllum commune (Split gill), Hygrocybe conica (witch’s hat), Hygrophorus sp. 
and Polyporus sp. (Bracket fungi) are sold in local Malaysian markets, with great eco-
nomical interest for local people as a source of income. Although research has focused 
mainly on the therapeutic effects and cultivation methods of mushrooms. Little infor-
mation is available about their biological properties. In addition, while many studies 
have focused on cultivated and wild edible mushrooms in the northern hemisphere, 
there are limited data in the literature concerning the antioxidant properties of the edible 
wild mushrooms from Southeast Asia, especially Malaysia (Wong & Chye, 2009). 
Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde previously known as 
Panus giganteus (Berk.) Corner is a medicinal and a culinary mushroom consumed by 
selected indigenous communities in Malaysia. It is domesticated strain from china 
which currently being considered for large scale cultivation. This study was performed 
to profile chemically a potentially interesting species Pleurotus giganteus which has not 
yet been characterized in the literature. The most common method used in the isolation 
of bioactive compounds from natural products is column chromatography which based 
on absorption chromatography. The mobile phase (e.g. solvents) moves a mixture of 
substances through the stationary phase (e.g. silica gel beads). The different compounds 
in the sample have different affinities for the mobile and stationary phase, and appear 
from the stationary phase at different times. The stationary phase and mobile phase are 
chosen based on the nature of the sample mixture in order to achieve the best possible 
separations of compounds. Column chromatography is advantageous over most other 
chromatographic techniques because it can be used in both analytical and preparative 
applications. Besides determining the number of components of a mixture, column 
chromatography can also be used to separate and purify substantial quantities of those 
components for subsequent analysis. Thus, in this study, the above mentioned strategy 
 4 
 
for identifying new lead compounds from the fruiting bodies of Pleurotus giganteus is 
adopted. 
The objectives of the present study were: 
i. To assess the chemical profile of Pleurotus giganteus from the aqueous, hexane, 
butanol, ethyl acetate and methanol extracts. 
ii. To identify the essential oils in the essential oil extract. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Mushrooms 
Mushrooms have a great nutritional value since they are quite rich in protein, with an 
important content of essential amino acids and fiber, and poor in fat. Edible mushrooms 
also provide a nutritionally significant content of vitamins (B1, B2, B12, C, D, and E). 
Edible mushrooms could be a source of many different nutraceuticals such as unsaturat-
ed fatty acids, phenolic compounds, tocopherols, ascorbic acid and carotenoids. Thus, 
they might be used directly in diet and promote health, taking advantage of the additive 
and synergistic effects of all the bioactive compounds present. More than 3000 mush-
rooms are said to be ‘‘the main edible species’’, of which only 100 are cultivated com-
mercially, and only 10 of those on an industrial scale (Reis et al., 2011). Their global 
economic value is nevertheless now staggering, and a prime reason for the rise in con-
sumption is the above mentioned combination of their value as a food as well as their 
medicinal and nutraceutical values. Production of mushrooms continuously increases 
over time with China being the biggest producer (more than 1.5 million metric tons in 
2007). The most cultivated mushroom worldwide is Agaricus bisporus, followed by 
Lentinula edodes, Pleurotus spp. and Flammulina velutipes (Reis et al., 2011).With 
increasing cultivation of previously uncultivated mushrooms it has become important to 
perform scientific studies which contribute to the elaboration of nutritional databases of 
the consumed fungi species worldwide, allowing comparison between them. 
 
2.2 Antioxidants in mushrooms 
Maintenance of equilibrium between free radical production and antioxidant defences 
(enzymatic and non enzymatic) is an essential condition for normal organism function-
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ing. When this equilibrium has a tendency for the production of free radicals we say that 
the organism is in oxidative stress. In this situation, excess free radicals may damage 
cellular lipids, proteins and DNA, affecting normal function and leading to various dis-
eases. In aerobic organisms, the free radicals are constantly produced during the normal 
cellular metabolism, mainly in the form of Reactive Oxygen Species (ROS) and Reac-
tive Nitrogen Species (RNS) (Ferreira et al., 2009). Exposition of the organism to free 
radicals has led to the development of endogenous defence mechanisms to eliminate 
them. These defences were the response of evolution to the inevitability of ROS produc-
tion in aerobic conditions. Natural products with antioxidant activity may help the en-
dogenous defence system. In this perspective the antioxidants present in the diet assume 
a major importance as possible protector agents reducing oxidative damage. Particular-
ly, the antioxidant properties of wild mushrooms have been extensively studied and 
many antioxidant compounds extracted from these sources have been identified, such as 
phenolic compounds, tocopherols, ascorbic acid, and carotenoids. Wild mushrooms 
might be used directly in diet and promote health, taking advantage of the additive and 
synergistic effects of all the bioactive compounds present. The antioxidants found in 
mushrooms are mainly phenolic compounds (phenolic acids and flavonoids), followed 
by tocopherols, ascorbic acid and carotenoids (Ferreira et al., 2009). Phenolic acids can 
be divided into two major groups, hydroxybenzoic acids and hydroxycinnamic acids, 
which are derived from non-phenolic molecules benzoic and cinnamic acid, respectively 
(Ferreira et al., 2009). The overall effectiveness of a natural phenolic antioxidant de-
pends on the involvement of the phenolic hydrogen in radical reactions, the stability of 
the natural antioxidant radical formed during radical reactions, and the chemical substi-
tutions present on the structure. The substitutions on the structure are probably the most 
significant with respect to the ability of a natural antioxidant to participate in the control 
of radical reactions and to form resonance-stabilized natural antioxidant radicals. Previ-
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ous studies concerning the analysis of the phenolic components of wild mushrooms can 
be found in the literature (Puttaraju et al., 2006 and Ribeiro et al., 2006). 
 
2.3 Antioxidant properties of tropical wild edible mushrooms in Malaysia 
In a previous study (Wong & Chye, 2009),  selected species of wild edible mushrooms 
were obtained from the interior areas of East Malaysia to determine the total phenolics 
and antioxidant properties, including free radical scavenging, reducing power and metal 
chelating activities. Selected species of edible wild mushrooms were obtained through-
out the year from indigenous people who collect edible forest resources in various dis-
tricts of Sabah, East Malaysia. The wild mushrooms were identified as Pleurotus porri-
gens, Hygrocybe conica, Xerula furfuracea (Rooted oude), Schizophyllum commune 
and Polyporus tenuiculus (Pore fungus). Based on the results obtained, petroleum ether 
(PE) and methanolic extracts from these edible wild mushrooms were effective in 
DPPH radical scavenging and metal chelating ability (Wong & Chye, 2009).  
 
2.4  Antioxidant properties of commercially cultivated mushrooms in Malaysia 
Pleurotus sajor-caju  is a mushroom which is commerially cultivated in Malaysia but is 
not native to Malaysia. In a recent study, the chemical composition and in vitro antioxi-
dant activity of aqueous butanol and ethyl acetate extracts of Pleurotus sajor-caju were 
investigated. Twenty-two compounds comprising methyl esters, hydrocarbon fatty ac-
ids, ethyl esters, and sterols were identified in ethyl acetate extracts, while cinnamic 
acid, nicotinamide, benzeneacetamide, and 4-hydroxybenzaldyhde were identified in 
butanol extracts by gas chromatography−mass spectrometry and NMR analysis. The 
antioxidant activity was determined by a β-carotene bleaching method, ferric reducing 
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antioxidant power, trolox equivalent antioxidant capacity, and lipid peroxidation assays, 
while the total phenolic content in P. sajor-caju was assessed by Folin−Ciocalteau's 
method. The aqueous and butanol extracts exhibited the highest antioxidant activity, 
corresponding to the total phenolic content. The subfractions from the ethyl acetate ex-
tract (EP1, EP2, EP3, and EP4), however, showed moderate antioxidant activity. The 
regular consumption of P. sajor-caju as a part of our diet may render nutritional and 
nutraceuticals benefits for good health (Kanagasabapathy et al., 2011). 
 
2.5 Anticancer activities of mushrooms 
Compounds from mushrooms may enhance innate immune responses, resulting in anti-
tumor activities. Several mushroom polysaccharide have proceeded through phases I, II, 
and III clinical trials and are used extensively and successfully in Asia to treat various 
cancers and other diseases (Wasser, 2010). There are more than two dozen species of 
endophytic fungi can synthesize paclitaxel, one of the most important anticancer drugs 
known (Ng, 1998). 
In a previous study  (Chen et al., 2006),white button mushrooms (Agaricus 
bisporous) are a potential breast cancer chemopreventive agent, as they suppress 
aromatase activity and estrogen biosynthesis. The mushroom extract activity was 
evaluated in the estrogen receptor-positive/aromatase-positive MCF-7aro cell line in 
vitro and in vivo. Mushroom extract decreased testosterone-induced cell proliferation in 
MCF-7aro cells but had no effect on MCF-10A, a nontumorigenic cell line. The most 
potent mushroom chemicals are soluble in ethyl acetate. The major active compounds 
found in the ethyl acetate fraction are unsaturated fatty acids such as linoleic acid, 
linolenic acid, and conjugated linoleic acid (Chen et al., 2006). The interaction of 
linoleic acid and conjugated linoleic acid with aromatase mutants expressed in Chinese 
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hamster ovary cells showed that these fatty acids inhibit aromatase with similar potency 
and that mutations at the active site regions affect its interaction with these two fatty 
acids. Whereas these results suggest that these two compounds bind to the active site of 
aromatase, the inhibition kinetic analysis indicates that they are noncompetitive 
inhibitors with respect to androstenedione. Because only conjugated linoleic acid was 
found to inhibit the testosterone-dependent proliferation of MCF-7aro cells, the 
physiologically relevant aromatase inhibitors in mushrooms are most likely conjugated 
linoleic acid and its derivatives. The in vivo action of mushroom chemicals was shown 
using nude mice injected with MCF-7aro cells. The studies showed that mushroom 
extract decreased both tumor cell proliferation and tumor weight with no effect on rate 
of apoptosis. Therefore the study illustrated the anticancer activity in vitro and in vivo of 
mushroom extract and its major fatty acid constituents (Chen et al., 2006). 
“Lingzhi” (Ganoderma lucidum), a popular medicinal mushroom, has been used 
in China for longevity and health promotion since ancient times. Investigations into the 
anticancer activity of lingzhi have been performed in both in vitro and in vivo studies, 
supporting its application for cancer treatment and prevention. The proposed anticancer 
activity of lingzhi has prompted its usage by cancer patients. It remains debatable as to 
whether lingzhi is a food supplement for health maintenance or actually a therapeutic 
"drug" for medical proposes. Thus far there has been no report of human trials using 
lingzhi as a direct anticancer agent, despite some evidence showing the usage of lingzhi 
as a potential supplement to cancer patients. Cellular immune responses and mitogenic 
reactivity of cancer patients have been enhanced by lingzhi, as reported in two 
randomized and one nonrandomized trials, and the quality of life of 65% of lung cancer 
patients improved in one study (Yuen & Gohel, 2005). The direct cytotoxic and anti-
angiogenesis mechanisms of lingzhi have been established by in vitro studies; however, 
clinical studies should not be neglected to define the applicable dosage in vivo. At 
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present, lingzhi is a health food supplement to support cancer patients, yet the evidence 
supporting the potential of direct in vivo anticancer effects should not be 
underestimated. Lingzhi or its products can be classified as an anticancer agent when 
current and more direct scientific evidence becomes available ( Yuen & Gohel, 2005).  
In an effort to translate the Asian traditional medicines into western-accepted 
therapies, scientists have demonstrated that the extracts from fruit-bodies or mycelium 
of Phellinus linteus not only stimulate the hormonal and cell-mediated immune function 
and quench the inflammatory reactions caused by a variety of stimuli, but also suppress 
the tumor growth and metastasis. Mounting evidence from different research groups has 
shown that Phellinus linteus induces apoptosis in a host of murine and human 
carcinomas without causing any measurable toxic effects to their normal counterparts. 
Recently, research has been focused on the anti-tumor effect of Phellinus linteus, and in 
particular, on its ability to enhance some conventional chemotherapeutic drugs. These 
studies suggest Phellinus linteus to be a promising candidate as an alternative anticancer 
agent or a synergizer for existing antitumor drugs ( Zhu et al., 2008). 
 
2.6  Anti-cholesterol activity and statins of mushrooms 
Mevastatin, lovastatin and monacolins L are  members of the drug class of statins, used 
in combination with diet, weight-loss, and exercise for lowering cholesterol 
(hypolipidemic agent) in those with hypercholesterolemia to reduce risk 
of cardiovascular disease (Lewington et al., 2007). The mevastatin and lovastatin were 
the first statins discovered in fungi. Lovastatin was later found being produced in Pleu-
rotus ostreatus (oyster mushroom) (Campbell & Vedaras, 2010). Red yeast rice, pro-
duced by the fungus Monascus purpureus, naturally contains lovastatin, mevastatin, and 
monacolins L and J. Lentinula edodes (shiitake) contains the anticholesterol compound 
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eritadenine (Bisen et al., 2010). Zaragozic acids which also have been shown to be able 
to treat hypercholesterolemia  were first discovered in S. intermedia and L. elatius 
(Bergstrom et al., 1995). 
 
2.7 Anti-hormone and anti-inflammatory activity of mushrooms 
A small clinical study showed the extract of Agaricus subrufescens (agaricus blazei) 
had an anti-inflammatory effect. Animal studies noted extracts of Fomes fomentarius 
(amadou) could reduce inflammation. In cell culture, extracts of Geastrum saccatum 
(rounded earthstar) demonstrated anti-inflammatory activity (Forland et al., 2011, 
Guerradore et al., 2007, Park et al., 2004). Phellinus linteus is a medicinal mushroom 
that has been practiced in oriental countries for centuries to prevent ailments as diverse 
as gastroenteric dysfunction, diarrhea, haemorrhage and cancers. Niuchangchih is a 
basidiomycete endemic to Taiwan. It is well known as a Traditional Chinese Medicine, 
and Taiwanese aborigines used this species to treat liver diseases and food and drug 
intoxication. The compounds identified in Niuchangchih are predominantly 
polysaccharides, triterpenoids, steroids, benzenoids and maleic/succinic acid derivatives 
(Ao et al, 2009). The fruiting bodies and fermented products of Niuchangchih have 
been reported to exhibit activity when treating liver diseases, such as preventing 
ethanol-, CCl(4)- a ameliorating fatty liver, liver fibrosis, and inhibiting liver cancer 
cells (Ao et al, 2009). 
 
2.8 Wild edible mushrooms in Malaysia 
There are over 90 different groups of indigenous people in Malaysia each with their 
own distinct language and culture, with the majority being found in the states of Sabah 
and Sarawak on the island of Borneo. The indigenous minority peoples of Peninsular 
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Malaysia collectively called the Orang Asli, are composed of 18 subethnic groups clas-
sified under the three major tribes of the Negrito, Senoi and Proto-Malays with a popu-
lation of 149,512 persons in 2004. The Orang Asli and other rural communities in Ma-
laysia are known to utilize certain local wild mushrooms for food, medicine and spiritu-
al purposes (Lee et al., 2009). In a recent study carried out by Lee and co-workers doc-
umented at least 31 species of macrofungi collected for food but only 14 species were 
used for medicinal purposes. Therefore scientific validation of culinary-medicinal prop-
erties of these mushrooms and specially their products was needed to provide evidence 
of credibility of claims.  
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Materials and instrumentation 
Evaporation of solvents was performed with a Butchi Rotavapor R-114 with an accom-
panying chiller B-741, waterbath B-480 and vacuum system V-700. A freeze-dryer 
from Christ was also used. Various chemicals and solvents from Merck were used 
which included acetone ((CH3)2CO), butanol (C4H9OH), ethanol (CH3CH2OH), hexane 
(C6H14), ethyl acetate (CH3COOCH2CH3), methanol (CH3OH), acetonitrile (CH 3CN), 
formic acid (CH2O2), ammonium formate (NH4HCO2).  Silica gel beads (size: 0.063 – 
0.200nm, 0.015-0.040nm) was used. The supplier of the silica gel was sigma-aldrich. A 
heating mantle (5 litre capacity) from topo (Germany) was also used. 
 
 GC – MS analysis 
The GC - MS analysis was performed on a Agilent Technologies 6890 N gas chroma-
tography equipped with a 5979 Mass Selective Detector (70 eV direct inlet); a HP-5 ms 
(5% Phenyl-methylpolysiloxane) capillary column (30.0 m × 250 μm ID × 0.25 μm film 
thickness) initially set at 150°C, then programmed to 280°C at 5°C per min using heli-
um as carrier gas at a flow rate of 1 ml/min was used. The total ion chromatogram ob-
tained was auto-integrated by Chemstation and the constituents were tentatively identi-
fied by comparison with the accompanying mass spectra data (NIST Lib, 2005) when-
ever possible. 
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 LCMS/MS analysis 
The LC-MS/MS analysis was performed on AB Sciex Liquid chromatography tandem 
MS-MS. The column used was phenomenex aqua C18-50mm x 2.0mmx 5μm. The mo-
bile phase A was 100% Acetonitrile. Mobile phase B was water and acetonitrile with 
0.1% formic acid and 5mM ammonium formate. The gradient run program was 10% A 
and 90% B initially and then was ramped up to 90% A and 10% B from 0.01min to 
8.0min. This was then held for two  minutes and then back to 10% A in 0.1 minutes and 
re-equilibrated for five minutes. Compounds were positively identified by NIST 06 
Database and ACD/labs advanced chemometrics mass fragmentation predictive 
software. 
 
3.2 Thin Layer Chromatography 
Thin layer chromatography (TLC) was carried out using pre-coated TLC plates 60 F254 
(20.25 mm thickness) and were visualized in UV light (254 and/or 365 nm) and /or io-
dine vapour. 
 
3.3 Sample Collection 
Fresh fruiting bodies of Pleurotus giganteus were collected from Nas Agro farm in 
Sepang, Selangor, Malaysia on the 14
th
 of April 2011. 
 
3.4 Extraction and fractionation of the ethyl acetate extract  
The five kg fresh fruiting bodies were washed, sliced and freeze-dried for two days. The 
freeze-dried mushrooms were ground to a fine powder using a blender. The dried, 
ground sample (404.10g, 8.08%) was then soaked in a 1.5L solution methanol and water 
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solution (8:2) for three days at room temperature. The solvent-containing extract was 
then decanted and filtered. The extraction of the ground sample was further repeated 
(3×) with 1.5L of methanol and water (8:2). The filtrate from each extraction was com-
bined and the excess solvent was evaporated under reduced pressure using a rotary 
evaporator to give a light- brown thick extract (8.95g, 2.22%).The percent yield is based 
upon the initial sample of 404.10g. The methanol extract was further partitioned with a 
mixture of ethyl acetate and water (1:1) to give an ethyl acetate-soluble fraction 
(PGETHYL1) and aqueous-soluble fraction. The aqueous extract was further extracted 
with butanol to obtain a butanol extract which was a dark yellowish extract (1.80g, 
0.45%). Evaporation of solvent from the ethyl acetate layer gave an extract (2.50g, 
0.62%) which was further fractionated using varying ratios of acetone: hexane as the 
eluting solvent. The aqueous extract was freeze dried to give a dark brown extract 
(6.45g, 1.60%). 
The ethyl extract sample (2.50g) was suspended in chloroform and then ad-
sorbed on to silica gel (size: 0.015-0.040nm) and silica was added until the consistency 
of silica with adsorbed sample reached a powdery state. The flash column was filled up 
with silica gel (size: 0.063-0.200nm) and the silica with absorbed sample was applied in 
an overlay fashion to the coarser silica. Elution began with 100% hexane and polarity of 
eluting solvent was gradually increased using acetone. Fractions of 200-400ml volumes 
were collected. The excess solvent in the pooled fractions was evaporated under re-
duced pressure using a rotary evaporator.  The separations were monitored using thin 
layer chromatography. The fractions were collected by gradient elution of 
hexane/acetone (h/A, v/v): h/A 100:0, 400 ml; h/A 99.5:0.5, 400 ml;  h/A 99:1, 400 ml; 
h/A 98.5:1.5, 400 ml h/A 98:2, h/A 97.5:2.5, 400 ml; h/A 97:3, h/A 96.5:3.5,  400 ml; 
h/A 96:4, 400 ml; h/A 95:5, 400 ml; h/A 94:6, 400 ml; h/A 93:7, 400 ml; h/A 92:8, 400 
ml; h/A 91:9, 400 ml; h/A 90:10, 400 ml; h/A 89:11, 400 ml; h/A 88:12, 400 ml; h/A 
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87:13, 400 ml; h/A 86:14, 400 ml; h/A 85:15, 400 ml; h/A 84:16, 400 ml ml; h/A 83:17, 
400 ml; h/A 82:18, 400 ml; h/A 81:19, 400 ml; h/A 80:20, 400 ml; h/A 79:21, 400 ml; 
h/A 78:22, 400 ml h/A 77:23, 400 ml; h/A 76:24, 400 ml; h/A 75:25, 400 ml; h/A 
74:26, 400 ml h/A 73:27, 400 ml ml; h/A 72:28, 400 ml; h/A 71:29, 400 ml; h/A 70:30, 
400 ml h/A 65:35, 400 ml; h/A 60:40, 400 ml; h/A 55:45, 400 ml; h/A 50:50, 400 ml 
h/A 45:55, 400 ml; h/A 40:60, 400 ml; h/A 35:65, 400 ml h/A 30:70, 400 ml ml; h/A 
25:75, 400 ml; h/A 20:80, 400 ml; h/A 15:80, 400 ml h/A 10:90, 400 ml; h/A 100:0, 
400 ml. The fractions with a similar TLC profile were combined and yielded fractions 
PGF 9 (1.1mg), PGF10 (1.1mg), PGF12 (1.0mg),  PGF31 (1.1mg),  PGF37 (1.0mg),  
PGF39 (1.0mg),  PGF41 (1.5mg), and  PGF46 (1.3mg). The fractions were analysed for 
the identification of unknowns by GC-MS and LC-MS/MS. The extraction and frac-
tionation of ethyl acetate extract of P. giganteus is shown in Figure 1.1. 
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Figure 1.1 
Extraction and fractionation of ethyl acetate extract of P. giganteus  
Fresh Pleurotus giganteus (5000 g) 
Dried and ground powder (404.10 g, 8.80 %) 
 
 
Crude methanol aqueous extract (8.95 g, 2.20 %) 
Partitioning with ethyl acetate: water (1:1) 
 
Ethyl acetate-soluble fraction 
Freeze- dried 
Aqueous-soluble fraction 
Filtration and evaporation of 
excess solvent 
 Ethyl acetate extract 
(2.50 g, 0.62 %) 
1. Extraction with methanol : water (8:2) for 3 days at room 
temperature 
2. Filtered 
3. Evaporation of solvent in filtrate 
 
Water extract 
(6.45 g, 1.60 %) 
 
 
Butanol extract 
(1.80 g, 0.45%) 
Identified secondary metabolites 
Extraction with n-butane 
 
GCMS/LCMS/MS    
Column chromatography 
Hexane: acetone 
   
  
PGF 
(1.1 mg) 
PGF12 
(1.0 mg) 
PGF10 
(1.1 mg) 
PGF37 
(1.0 mg) 
PGF41 
(1.5 mg) 
 
PGF31 
(1.1 mg) 
PGF39 
(1.0 mg) 
PGF46 
(10.0 mg) 
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3.5  Extraction and fractionation hexane extract  
The five kg fresh fruiting bodies were washed, sliced and freeze-dried for two days. The 
freeze-dried mushrooms were ground to a fine powder using a blender.  The dried, 
ground sample (403.2g) was soaked in hexane (1.5 L) for 3 days at room temperature. 
The solvent-containing extract was then decanted and filtered. The extraction of the 
ground sample was further repeated (3×) with 1.5 L each time. The filtrate from each 
extraction was combined and the excess solvent was evaporated under reduced pressure 
using a rotary evaporator to give a light- brownish thick extract (0.1g, 0.02%). The yield 
is based upon the initial 403.2g sample.  
The hexane extract (0.1g) was dissolved in chloroform and then absorbed on to 
silica gel (size: 0.015-0.040nm) and silica was added until the consistency of silica with 
adsorbed sample reached a powdery state. The flash column was filled up with silica gel 
(size: 0.063-0.200nm) and the silica with adsorbed sample was applied in an overlay 
fashion to the coarser silica. Elution began with 100% hexane and polarity of eluting 
solvent was gradually increased using acetone. Fractions of 200-400ml volumes were 
collected. The excess solvent in the pooled fractions was evaporated under reduced 
pressure using a rotary evaporator.  The separations were monitored using thin layer 
chromatography. The fractions were collected by gradient elution of hexane/acetone 
(h/A, v/v): h/A 100:0, 400 ml;  h/A 99:1, 400 ml; h/A 98:2, , 400 ml; h/A 97:3, 400 ml; 
h/A 96:4, 400 ml; h/A 94:6, 400 ml; h/A 93:7, 400 ml; h/A 92:8, 400 ml; h/A 91:9, 400 
ml; h/A 90:10, 400 ml; h/A 85:15, 400 ml; h/A 80:20, 400 ml; h/A 75:25, 400 ml; h/A 
70:30, 400 ml; h/A 65:35, 400 ml; h/A 60:40, 400 ml ml; h/A 55:45, 400 ml; h/A 25;75, 
400 ml; h/A 00:100, 400 ml. The fractions with a similar TLC profile were combined 
and yielded fractions PGHEX4 (1.0mg), PGHEX5 (1.1mg), PGHEX10 (1.0mg),  
PGHEX16 (1.1mg) and PGHEX19 (1.0mg).The fractions were analysed for the identi-
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fication of unknowns  by GC-MS and LC-MS/MS . The hexane extraction and fraction-
ation of the fresh fruiting bodies of Pleurotus giganteus is shown in Figure 1.2. 
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Figure 1.2 
Extraction and fractionation of hexane extract of P. giganteus 
  
Fresh Pleurotus giganteus (5000g) 
Dried and ground powder (403.20g, 8.06%) 
 
 
Crude hexane aqueous extract (0.10g, 0.03%) 
Column chromatgrapgy (hexane:acetone) 
 
1. Extraction with hexane : water (8:2) for 3 days 
at room temperature 
2. Filtered 
3. Evaporation of solvent in filtrate 
PGHEX4 
(1.0mg) 
PGHEX5 
(1.1mg) 
 
PGHEX10 
(1.0mg) 
 
PGHEX16 
(1.1mg) 
 
PGHEX19 
(1.0mg) 
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3.6 Extraction and fractionation of aqueous extract  
Components of the aqueous extract were identified using LCMS/MS. Samples were 
dissolved in 50:50 acetonitrile and water. 
 
3.7  Extraction and identification of essential oils of Pleurotus giganteus 
3.7.1 Sample collection 
 1 kg of the fresh fruiting bodies of Pleurotus giganteus was collected from a mushroom 
farm in Sepang, Selangor (14
th
 April 2011).  
 
3.7.2 Extraction of essential oils from fruiting bodies  
Fresh fruiting bodies of Pleurotus giganteus (1kg) was collected from a mushroom farm 
in Sepang, Selangor (14
th
 April 2011). The fresh fruiting bodies were washed and sliced 
and diced. The mushrooms were then placed in a 5L round bottom flask which was 
filled with water. The round bottom flask was then placed on a heating mantle. A 
Clevenger unit was attached to the top of the round bottom flask and the evaporated oils 
were collected. The oil collected was a pale yellow colour.  
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  CHAPTER 4 
RESULTS 
 
4.1 Identification of compounds in ethyl acetate extract 
The ethyl acetate extract was subjected to column chromatography and a total of forty 
one fractions were collected from the column chromatography. The fractions were 
pooled according to the spots on TLC plates (Table1.1) and several fractions were ob-
tained. The Table 4.1 below shows the details of fractions obtained from ethyl acetate. 
 
Table 4.1 
Fractions obtained from ethyl acetate extract using column chromatography 
Pooled Vials Weight (mg) Vials Appearance 
PGF9 1.0mg 1-9 Yellow oil 
PGF10 1.1mg 10-11 Colourless crystals 
PGF12 1.0mg 12-13 Colourless crystals 
PGF31 1.1mg 28-31 Colourless oil 
PGF37 1.0mg 34-37 Colourless oil 
PGF39 1.0mg 38-39 Colourless oil 
PGF41 1.5mg 37-41 Yellow oil 
 
Table 4.1 shows the components present in the unfractionated ethyl acetate ex-
tract (PGETHYL1) as identified by GC/MS. Four components comprising of about 
67.5% of the total ethyl acetate extract were identified with methyl linoleate (50.28%) 
forming the major constituent. 
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Table 4.2 
Compounds in PGETHYL1 identified by GC-MS 
 
 
  
Compounds Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Hexadecanoic acid, methyl 
ester 
(Methyl palmitate ) 
23.897 10.58 270.45 C17H34O2 
 
9, 12 – Octadecadienoic 
acid, methyl ester 
(Methyl linoleate) 
35.965 50.28 294.47 C19H34O2 
 
Unidentified compound 36.484 7.80 - - 
Octadecanoic acid, methyl 
ester 
(Methyl Stearate) 
38.743 2.26 298.29 C20H40O2 
Unidentified compound 64.777 1.21 - - 
Unidentified compound 70.532 9.09 - - 
Unidentified compound 79.714 2.08 - - 
Unidentified compound 94.733 1.75 - - 
Ergosterol 109.796 4.38 396.65 C28H44O 
Total amount : 89.43% 
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In Figure 4.1 the peak at retention time 23.867 minutes has a mass spectral data 
consistent with methyl palmitate. The mass spectrum exhibited a parent ion at m/z 270 
that is consistent with the molecular formula C17H34O2. The mass spectral data is as 
follows m/z (%): 270 ([M]
+
,12),239 ([M-OCH3]
+
,10) 227([M-CH2COH]
+
,12), 213 ([M- 
CH2COH-CH2]
+
,10),199 ([M- CH2COH-(CH2)2]
+
,4), 185 ([M- CH2COH-(CH2 )3]
+
,5), 
171 ([M- CH2COH-(CH2 )4]
+
,5), 157 ([M- CH2COH-(CH2)5]
+
,3), 143 ([M- CH2COH-
(CH2)6]
+
,20), 129 ([M- CH2COH-(CH2)7]
+
,10),87([C4H7O2]
+
,70), 74 ([C3H6O2]
+
,100), 
55 .  
 
Figure 4.1 
Mass spectrum of methyl palmitate 
 
In Figure 4.2 the peak at retention time 35.965 minutes has a mass spectral data 
consistent with methyl linoleate. The mass spectrum exhibited a parent ion at m/z 294 
that is consistent with the molecular formula C19H34O2. The mass spectral data is as 
follows m/z (%): 294([M]
+
, 20), 263([M-CH3O]
+
15), 245, 220([M-CH3O-C2H3O]
+
7) 
150, 109, 95, 81, 67 (100), 55.  
H3C O
O
CH3 
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Figure 4.2 
Mass spectrum of methyl linoleate 
 
In Figure 4.3 the peak at retention time 38.742 minutes has a mass spectral data 
consistent with methyl stearate. The mass spectrum exhibited a parent ion at m/z 298 
that is consistent with the molecular formula C19H38O2. The mass spectral data is as 
follows m/z (%): 298 (M
+
, 20), 267 ([M-OCH3]
+
, 15)
,
 255 ([M-OC2H3]
+ 
22), 241, 213, 
199, 185, 171, 157, 143([M - C3H7 - C2H4 - C4H8]
+
, 30), 129, 111, 97, 87 ([M - C3H7 - 
C2H4 - C4H8 - C4H8]
+
, 80), 74(100), 55. 
 
Figure 4.3  
Mass spectrum of methyl stearate 
 
 
 
H3C
O
O
CH3
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Table 4.3 shows the constituents of fractionated ethyl acetate sample (PGF9), 
representing fraction 1-9 pooled together. Compounds in the sample were identified 
through GC-MS analysis. Four components comprising of 66.80% of the PGF9 fraction 
were identified with palmitic acid (53.59%) forming the major constituent. The next 
major component (31.22%) at retention time 47.524 could not be identified. 
 
Table 4.3  
Compounds in PGF9 identified by GC-MS 
  
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Benezeneacetic acid, alpha. 
– hydroxyl-, methyl ester 
(Methyl mandelate) 
38.598 11.69 166.17 C9H10O3 
 
 p-tert-butyl-phenol 
( 4-tert-Butylphenol) 
39.930 0.62 150.21 C10 H14 O 
Unidentified compound 47.524 31.22 - - 
Phenol, 2 ,5-bis (1,1-
dimethylethyl) 
( Phenol, 2,5-di-tert-butyl) 
65.909 0.90 206.32 C14H22O 
 
n-Hexadecanoic acid 
(Palmitic acid) 
113.768 53.59 256.22 CH3(CH2)14C
OOH 
Total amount : 98.02% 
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In Figure 4.4 the peak at retention time 38.598 minutes has a mass spectral data 
consistent with methyl mandelate. The mass spectrum exhibited a parent ion at m/z 166 
that is consistent with the molecular formula C9H10O3. The mass spectra data is as fol-
lows m/z (%):  166 (M
+
, 10), 150, 118, 107 ([M-CH3COO]
+ 
100), 91, 79, 51. The base 
peak at m/z 107 is consistent with the loss of CH3COO
-
 moiety from the molecular ion. 
 
Figure 4.4 
Mass spectrum of methyl mandelate. 
 
In Figure 4.4 the peak at retention time 39.930 minutes has a mass spectral data 
consistent with 4-tert-butylphenol. The mass spectrum exhibited a parent ion at m/z 150 
that is consistent with the molecular formula C19H34O2. The mass spectra data is as fol-
lows m/z (%):  150 (M
+
, 10), 135([M- CH3]
+
, 100), 107([M- CH3-C2H4]
+ 
, 30), 95. 
  
HO
H
O
O
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Figure 4.5 
Mass spectrum of 4-tert-butylphenol 
 
In Figure 4.6 the peak at retention time 65.909 minutes has a mass spectral data 
consistent with 2, 5-di-tert-butylphenol. The mass spectrum exhibited a parent ion at 
m/z 206 that is consistent with the molecular formula C10 H14 O .The mass spectra data 
is as follows m/z (%):  206 (M
+
, 20), 191 ([M- CH3]
+ 
,100), 163, 91, 74, 57. 
 
 
Figure 4.6 
Mass spectrum of 2, 5-di-tert-butylphenol 
 
In Figure 4.7 the peak at retention time 113.774 minutes has a mass spectral data 
consistent with palmitic acid. The mass spectrum exhibited a parent ion at m/z 256 that 
is consistent with the molecular formula C16H32O2. The mass spectral data is as follows 
HO  
HO
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m/z (%): 256 ([M]
+
,12), 227([M-CHO]
+
,2), 213 ([M-CHO-CH2]
+
,10),199 ([M-CHO-
(CH2)2]
+
,4), 185 ([M-CHO-(CH2 )3]
+
,5), 171 ([M-CHO-(CH2 )4]
+
,5), 157 ([M-CHO-
(CH2)5]
+
,7), 143 ([M-CHO-(CH2)6]
+
,3), 129 ([M-CHO-(CH2)7]
+
,50), 73 
([(CH2)2COOH]
+
,100), 60 (C2H4O2
+
, 90). The base peak at m/z 60 is a characteristic 
peak resulting from the McLafferty rearrangement. Besides the McLafferty rearrange-
ment peak, the spectrum also showed loss of clusters of 14 (CH2) mass units typical of 
long–chain carboxylic acid. 
 
 
Figure 4.7 
Mass spectrum of palmitic acid 
 
Table 1.4 shows the constituents of fractionated ethyl acetate sample (PGF10). 
Four components comprising of 21.35% of the PGF10 fraction were identified with 
ergosterol (20.44%) forming the major constituent. The largest major component 
(41.59%) at retention time 42.245 could not be identified. 
  
O
OH  
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Table 4.4  
Compounds in PGEF10 identified by GC-MS 
 
In Figure 4.7 the peak at retention time 13.721 minutes has a mass spectral data 
consistent with myristic acid. The mass spectrum exhibited a parent ion at m/z 228 that 
is consistent with the molecular formula C14H28O2. The mass spectra data is as follows 
m/z(%): 228 (M
+
, 15), 199 ([M-CHO]
+
, 7), 185 ([M-CHO- CH2]
+
, 25), 171([M-CHO- 
(CH2)2]
+
, 20), 157 ([M-CHO- (CH2)3]
+
, 20), 143 ([M-CHO- (CH2)4]
+
, 20), 129 ([M-
CHO- (CH2)5]
+
, 50), 115, 107, 97, 85, 73, 60([CH2COHOH]
+
,100). 
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Tetradecanoic acid 
( Myristic acid) 
13.721 0.17 228.37 C14H28O2 
Unidentified compound 28.321 20.81 228.37 C14H28O2 
Unidentified compound 42.245 41.59 - - 
Unidentified compound 43.477 8.48 - - 
Ergosterol  110.340 20.44 396.65 C28H44O 
Neoergosterol 111.798 0.74 380.61 C27H40O 
 
Total amount : 92.23% 
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Figure 4.8 
Mass spectrum of myristic acid 
 
In Figure 4.9 the peak at retention time 110.340 minutes has a mass spectral data 
consistent with ergosterol. The mass spectrum exhibited a parent ion at m/z 396 that is 
consistent with the molecular formula C28H44O. The mass spectral data is a as follows 
m/z (%):  396 (M
+
, 15), 378([M-H2O]
+
, 5)363, 337, 253, 157, 143, 81, 69([(CH) 
CHCH=CH]
+
, 99), 55 ([C4H7]
+
, 100). 
 
 
Figure 4.9 
Mass spectrum of ergosterol 
 
In Figure 4.10 the peak at retention time 111.798 minutes has a mass spectral 
data consistent with neoergosterol. The mass spectrum exhibited a parent ion at m/z 380 
O
OH 
HO
H H
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that is consistent with the molecular formula C27H40O. The mass spectral data is a as 
follows m/z(%): 380 (M
+ 
, 20), 362 ([M- H20]
+
, 15), 319 ([M- H20- C3H7]
+
, 8), 282, 
267, 253, 237, 225, 213,195, 183, 165, 153, 141, 128,109,95, 81,69 ([(CH) 
CHCH=CH]
+
75), 55 M 
+
- ([CH(CH3)CH(CH3)2]
+
, 100). 
 
 
Figure 4.10 
Mass spectrum of neoergosterol 
 
Table 4.5 represents components identified in fraction PGF31. One phenolic 
compound, benzeneacetic acid, was identified in this fraction. 
 
 
 
 
 
 
 
HO
H
CH3
CH3
CH3
CH3
H3C
H
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Table 4.5  
Compounds in PGF31 identified by GC-MS 
 
In Figure 4.11 the peak at retention time 8.635 minutes has a mass spectral data 
consistent with α-toluic acid. The mass spectrum exhibited a parent ion at m/z 136 that 
is consistent with the molecular formula C8H8O2. The mass spectral data is as follows 
m/z (%):  136 (M
+
, 40), 118([M- H2O]
+
, 2), 91([M- COOH]
+
100), 65. 
 
 
 
 
Compounds  Retention 
Time (minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Benzeneacetic acid 
( α-Toluic acid) 
8.641 1.89 136.15 C8H8O2 
Unidentified compound 17.272 3.21 - - 
Unidentified compound 19.638 8.24 - - 
Unidentified compound 40.168 12.37 - - 
Unidentified compound 89.066 9.41 - - 
Unidentified compound 102.371 35.90 - - 
Total amount : 71.02% 
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Figure 4.11 
Mass spectrum of α-toluic acid 
 
Table 4.6 shows the compounds identified in fraction PGF37, representing frac-
tion thirty four to thirty seven pooled together. One compound, nicotinamide, was iden-
tified in this fraction. 
  
O
OH
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Table 4.6  
Compounds in PGF37 identified by GC-MS analysis 
 
In Figure 4.12 the peak at retention time 51.966 minutes has a mass spectral data 
consistent with nicotinamide acid. The mass spectrum exhibited a parent ion at m/z 136 
that is consistent with the molecular formula C6H6N2O. The mass spectral data as fol-
lows m/z (%): 122 (M
+,
 100), 106 ([M-NH2]
+
, 60), 78 ([M-NH2-CO], 80), 51. 
 
 
Figure 4.12 
Mass spectrum of nicotinamide 
 
  
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
3-Pyridinecarboxamide 
(Nicotinamide) 
51.966 1.07 122.12 C6H6N2O 
Oleic acid 114.037 95.55 282.46 C18H34O2 
Total amount : 96.62% 
N NH2
O
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Table 4.7 showed components in fraction PGF39. The peak at retention time 
32.516 minutes has a mass spectral data consistent with 3, 4- dimethoxy-benzaldehyde 
(methyl vanillin). 
 
Table 4.7  
Compounds in PGF39 (fraction thirty nine of ethyl acetate sample) identified by GC-
MS 
 
The mass spectrum in Figure 4.13 the exhibited a parent ion at m/z 166 that is consistent 
with the molecular formula C8H8O2. The mass spectral data is as follows m/z (%):  166 
(M
+
, 100), 151([M- CH3]
+ 
11), 137, 122, 107, 95, 77, 65, 51. 
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Unidentified compound 11.062 5.17 - - 
Unidentified compound 11.319 9.45 - - 
Unidentified compound 17.061 4.96 - - 
Unidentified compound 19.119 18.08 - - 
3,4- dimethoxy- benzalde-
hyde 
( Methyl vanillin) 
 
32.516 12.96 166.17 C9H10O3 
 
Unidentified compound 36.446 10.21 - - 
Total amount : 60.83% 
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Figure 4.13 
Mass spectrum of methyl vanillin 
 
4.2 Identification of compounds in hexane extract 
The hexane extract (0.1g) was subjected to column chromatography, eluting with 100 % 
hexane followed by hexane enriched with increasing percentages of acetone. The eluted 
compounds were monitored using TLC. A total of 34 fractions were collected from the 
column chromatography. The fractions were pooled according to the spots on TLC 
plates.  Components in the isolated fractions were identified using GC-MS. Table 1.8 
shows the physical characteristics of the isolated fractions.  
 
Table 4.8  
Fractions obtained from hexane extract using column chromatography 
Pooled Vials Weight (mg) Vials Appearance 
PGHEX4 1.0mg 1-4 Yellow oil 
PGHEX5 1.1mg 5 Colourless crystals 
PGHEX10 1.0mg 6-10 Colourless crystals 
PGHEX16 1.1mg 12-16 Colourless oil 
PGHEX19 1.0mg 18-19 Colourless oil 
 
  
O
O
H3C
CH3O
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Table 4.9 showed components identified in PGHEX4 fraction. Two components 
comprising 25.77% of the PGHEX4 subfraction were identified with methyl linoleate 
(15.58%) forming the major component whilst palmitic acid (10.19%) formed the next 
major component. 
 
Table 4.9  
Compounds in PGHEX4 fraction identified by GC-MS 
 
In Figure 4.14 the peak at retention time 16.598 minutes has a mass spectral data 
consistent with methyl linoleate. The mass spectrum exhibited a parent ion at m/z 294 
that is consistent with the molecular formula C8H8O2. The mass spectral data is as fol-
lows m/z (%):  294, 263([M- CH3O]
+  
5), 220, 206, 191, 178, 164, 150, 135, 123, 109, 
95, 81, 67 (100), 55. 
Compounds  Retention 
Time 
(minutes) 
 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
n-Hexadecanoic acid 
(Palmitic acid) 
13.202 10.19 256.22 CH3(CH2)14C
OOH 
9, 12 Octadecadienoic  
acid, methyl ester 
(Methyl linoleate) 
16.592 15.58 294.47 C19H34O2 
Unidentified compound 18.537 4.74 - - 
Unidentified compound 29.065 46.34 - - 
Total amount : 76.85% 
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Figure 4.14 
Mass spectrum of methyl linoleate 
 
Table 4.10  
Compounds in PGHEX5 fraction identified by GC-MS 
 
 
In Figure 4.14 the peak at retention time 18.212 minutes has a mass spectral data 
consistent with oleic acid. The mass spectrum exhibited a parent ion at m/z 282 that is 
consistent with the molecular formula C18H34O2 . The mass spectral data is as follows 
m/z (%): 282 (M
+
, 3), 264([M- H20]+, 10), 256, 235, 222, 207, 193([M - H2O - C2H5 - 
C3H6]
+
, 3),180, 165, 151, 137, 123, 111, 97, 83, 69,55([COOH]
+
 100). 
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Oleic acid 
((9Z)-Octadecenoic acid) 
18.212 68.05 282.46 C18H34O2 
Campesterol 44.778 0.95 400.68 C28H48O 
Total amount : 69.0% 
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Figure 4.15 
Mass spectrum of oleic acid 
 
In Figure 4.16 the peak at retention time 44.778 minutes has a mass spectral data 
consistent with campesterol. The mass spectrum exhibited a parent ion at m/z 400 that is 
consistent with the molecular formula C8H8O2. The mass spectral data is as follows m/z 
(%):  400 (M
+
, 80), 385([M- CH3]
+ 
30), 367, 273, 255 (100), 229, 213, 161, 147, 133, 
119, 107, 91, 79, 67, 55. 
 
 
Figure 4.16 
Mass spectrum of campesterol 
 
  
HO  
 
 
OH
CH3
O
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In table 4.11 only one phenolic compound benzeneacetic acid, 4-hydroxy-, me-
thyl ester comprising of 3.84% of the total PGHEX10 fraction was identified. Other 
components forming the major constituents could not be identified. 
 
Table 4.11  
Compounds in PGHEX10 fraction identified by GC-MS 
 
In Figure 4.17 the peak at retention time 3.937 minutes has a mass spectral data 
consistent with acetic acid, p-hydroxyphenyl- methyl ester. The mass spectrum exhibit-
ed a parent ion at m/z 166 that is consistent with the molecular formula C9H10O. The 
mass spectral data is as follows consistent m/z (%):  166 (M
+
, 25), 121, 107([M-
CH3CO2]
+
 100), 83, 77, 59, 51. 
 
 
  
Compounds Name Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Benzeneacetic acid, 4-
hydroxy-, methyl  ester 
(Acetic acid, (p-
hydroxyphenyl- methyl 
ester 
3.94 3.84 166.17 C9H10O3 
Unidentified compound 13.09 9.63 - - 
Unidentified compound 17.81 73.03 - - 
Unidentified compound 29.02 9.12 - - 
Total amount :95.62% 
 41 
 
 
Figure 4.17 
Mass spectrum of acetic acid, p-hydroxyphenyl- methyl ester 
 
Table 4.12 represents the fractionated hexane sample, representing fraction elev-
en to sixteen pooled together. One alkaloid compound N-acetylphenylethylamine was 
present in the hexane extract. 
 
Table 4.12 
 Compounds in PGHEX16 fraction identified by GC-MS 
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Acetamide, N-(2-
phenylethyl)- 
N-acetylphenylethylamine 
4.344 5.07 163.21 C10H13NO 
Unidentified compound 17.580 8.91 - - 
Unidentified compound 31.611 17.79 - - 
Unidentified compound 52.160 14.97 - - 
Unidentified compound 53.035 53.27 - - 
Total amount : 100% 
HO
O
O
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In Figure 4.17 the peak at retention time 4.344 minutes has a mass spectral data 
consistent with N-acetylphenylethylamine. The mass spectrum exhibited a parent ion at 
m/z 163 that is consistent with the molecular formula C10H13NO. The mass spectral data 
is as follows m/z (%):  163 (M
+
, 20), 118, 104([M- CH3CONH]
+
, 100), 91, 85, 77, 72, 
65, 51. 
 
 
Figure 4.18 
Mass spectrum of N-acetylphenylethylamine 
 
Table 4.13 represents the fractionated hexane sample, representing fraction sev-
enteen to nineteen pooled together. One phenolic compound tyrosol was identified. 
  
H
N
O
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Table 4.13  
Compounds in PGHEX19 Fraction identified by GC-MS 
 
In Figure 4.19 the peak at retention time 3.343 minutes has a mass spectral data 
consistent tyrosol. The mass spectrum exhibited a parent ion at m/z 138 that is con-
sistent with the molecular formula C8H8O2. The mass spectral data is as follows m/z 
(%):  138 (M
+
, 30), 107([M- CH2OH]
+
, 100), 91, 83, 77. 
 
 
Figure 4.19 
Mass spectrum of tyrosol 
  
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Benzeneethanol, 4 –
hydroxyl 
(Tyrosol) 
3.343 0.84 138.16 C10H13NO 
Unidentified compound 37.435 7.17 - - 
Unidentified compound 41.857 5.50 - - 
Unidentified compound 59.241 86.49 - - 
Total amount : 100% 
HO
OH
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4.3 Identification of compounds in aqueous extract 
Table 4.14 represents components identified in the aqueous extract. Succinic acid and 4 
phenolic compounds comprising of 16.19 % of the aqueous extract were identified. Ma-
jor compounds at retention times 5.82, 5.66, 6.94, 8.92 and 11.18 minutes representing 
13.72%, 26.44%, 12.56%, and 22.63% respectively, could not be identified. 
 
Table 4.14  
Components identified in the aqueous extract  
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Succinic Acid (Amber Ac-
id) 
0.97 12.57 118.08 C4H6O4 
Caffeic Acid 1.29 1.31 180.16 C9H8O4 
Benzoic Acid 
( Benzenecarboxylic acid) 
2.24 2.14 122.12 C7H6O2 
Hydroxylated Cinnamic 
acid (Coumaric Acid) 
2.58 0.07 164.16 C9H8O3 
Cinnamic Acid (trans-
Cinnamic Acid) 
2.75 0.10 148.16 C9H8O2 
Unidentified compound 5.66 0.22 - - 
Unidentified compound 5.82 13.72 - - 
Uridine (Uracil riboside) 6.79 0.55 244.2 C9H12N2O6 
Unidentified compound 6.94 26.44 - - 
Unidentified compound 7.27 0.64 - - 
Unidentified compound 8.42 12.56 - - 
 
Unidentified compound 11.18 22.63 - - 
Total amount : 93.59% 
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In Figure 4.20 the peak at retention time 0.965 minutes has a mass spectral data 
consistent amber acid. The mass spectrum exhibited a parent ion at m/z 117 that is con-
sistent with the molecular formula C4H6O4. The mass spectral data is as follows m/z 
(%):  117 (M-H, 75), 99, 74, 73 ([M-H–COO]+ , 100), 72, 70. 
 
Figure 4.20 
Mass spectrum of amber acid 
 
In Figure 4.21 the peak at retention time 2.261 minutes has a mass spectral data 
consistent benzenecarboxylic acid. The mass spectrum exhibited a parent ion at m/z 121 
that is consistent with the molecular formula C7H6O2. The mass spectral data is as fol-
lows m/z (%):  121 (M-H, 100), 120, 108, 93, 92, 91, 55. 
 
 
Figure 4.21 
Mass spectrum of benzenecarboxylic acid 
 
O
OH HO
O
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 In Figure 4.22 the peak at retention time 2.584 minutes has a mass spectral data 
consistent coumaric acid. The mass spectrum exhibited a parent ion at m/z 165 that is 
consistent with the molecular formula C9H8O3. The mass spectral data is as follows m/z 
165 (M-H, 80), 147 ([M-H –H2O]
+
, 100), 121, 119([M-H –H2O-CO]
+
, 60), 118, 117, 
103, 102, 101, 91, 89, 73. 
 
Figure 4.22 
Mass spectrum of coumaric acid 
 
In Figure 4.23 the peak at retention time 2.745 minutes has a mass spectral data 
consistent trans-cinnamic acid. The mass spectrum exhibited a parent ion at m/z 147 
that is consistent with the molecular formula C9H8O2. The mass spectral data is as fol-
lows m/z (%):  147(M-H, 100), 119([M-H –CO]+40), 103([M-H -CO-OH]+40), 77. 
 
 
Figure 4.23 
Mass spectrum of trans-cinnamic acid 
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In Figure 4.24 the peak at retention time 1.289 minutes has a mass spectral data 
consistent with caffeic acid. The mass spectrum exhibited a parent ion at m/z 181 that is 
consistent with the molecular formula C9H8O4. The mass spectral data is as follows m/z 
(%):   181(M-H, 100) 163([M-H –H2O]
+ 
,70), 135([M-H –H2O-CO]
+ 
,72), 134, 119, 
117, 107, 101, 93, 73. 
 
 
Figure 4.24 
Mass spectrum of caffeic acid 
 
In Figure 4.25 the peak at retention time 6.79 minutes has a mass spectral data 
consistent with uracil riboside. The mass spectrum exhibited a parent ion at m/z 243 that 
is consistent with the molecular formula C9H12N2O6. The mass spectra (%):  243 (M-H, 
100), 226, 225, 207, 199, 181, 153, 136, 123. 
 
 
Figure 4.25 
Mass spectrum of uracil riboside 
OH
O
HO
HO  
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4.4 Identification of compounds in essential oil 
Table 2.5 shows the results for the essential oil extract. Two compounds were identified 
in the essential oil extraction. They were benzyl alcohol and 2-phenyl-2-butenal. Both 
compounds together represented only 2.27% of the total essential oil content. Other ma-
jor peaks at retention times 30.354 and 70.071 minutes could not be identified. 
 
Table 4.15  
Components identified in essential oil 
 
In Figure 4.26 the peak at retention time 11.644 minutes has a mass spectral data 
consistent benzenemethanol. The mass spectrum exhibited a parent ion at m/z 108 that 
Compounds  Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Unidentified compound 7.071 14.28 - - 
Benzyl Alcohol 
(Benzenemethanol) 
11.644 1.01 108.14 C7H8O 
Unidentified compound 8.091 4.61 - - 
Benzeneacetaldehyde, al-
pha. –ethylidene 
( 2-Phenyl-2-Butenal) 
25.626 1.26 146.19 C10H10O 
 
Unidentified compound 30.053 15.40 - - 
Unidentified compound 30.354 44.54 - - 
Unidentified compound 33.950 4.58 - - 
Total amount : 85.68% 
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is consistent with the molecular formula C7H8O. The mass spectral data is as follows: 
m/z (%):  108(M
+
), 107([M-H]
+ 
65), 105, 91([M-OH]
+ 
20), 79([C6H5)]
+
, 100) 65, 57, 51. 
 
 
Figure 4.26 
Mass spectrum of benzenemethanol 
 
In Figure 4.27 the peak at retention time 25.262 minutes has a mass spectral data 
consistent with 2-phenyl-2-butenal. The mass spectrum exhibited a parent ion at m/z 
146 that is consistent with the molecular formula C7H8O.The mass spectral data is as 
follows m/z (%):  146(M
+
, 80), 131([M-CH3]
+
, 10), 115([M-CH3-CHO]
+
, 100), 102, 97, 
91, 78, 74. 
 
Figure 4.27 
Mass spectrum of 2-phenyl-2-butenal 
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4.5 Identification of compounds in butanol extract 
The butanol extract was run on GC-MS and LC-MS/MS. Only hydroxybenzoic acid 
amounting to 0.67% of the extract was identified in this fraction. No other peaks in the 
spectrum could be identified. 
 
Table 4.16  
Components identified in butanol extract  
  
Compounds Name 
 
Retention 
Time 
(minutes) 
Percentage 
(%) 
Molecular 
Weight 
Molecular 
Formula 
Unidentified compound 0.84 1.56 - - 
Hydroxybenzoic acid 1.29 0.67 138.12 C7H6O3 
Unidentified compound 2.58 0.54 - - 
Unidentified compound 2.91 0.78 - - 
Unidentified compound 5.82 3.78 - - 
Unidentified compound 6.15 3.12 - - 
Unidentified compound 7.57 5.45 - - 
Unidentified compound 7.95 2.78 - - 
Unidentified compound 9.43 4.89 - - 
Unidentified compound 9.88 10.23 - - 
Unidentified compound 10.25 21.67 - - 
Unidentified compound 11.54 20.45 - - 
Unidentified compound 12.69 10.56 - - 
Unidentified compound 13.47 9.23 - - 
Total: 95.71% 
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In Figure 4.28 the peak at retention time 1.287 minutes has a mass spectral data 
consistent with hydroxybenzoic acid. The mass spectrum exhibited a parent ion at m/z 
137 that is consistent with the molecular formula C9H8O4. The mass spectral data is as 
follows m/z (%): 137 (M+H, 75), 81(100), 79, 63.  
    
 
Figure 4.28 
Mass spectrum of hydroxybenzoic acid 
 
  
HO
OH
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CHAPTER 5 
DISCUSSION 
 
5.1 Fatty acids and their methyl esters 
The fruiting bodies of Pleurotus giganteus is composed of several fatty acids and esters 
of fatty acids. Palmitic acid, methyl palmitate, methyl linoleate, methyl stearate, methyl 
mandelate, myristic acid are some of the fatty acids and fatty esters identified in Pleuro-
tus giganteus.  The composition of methyl stearate, methyl palmitate acid and methyl 
linoleate in the total ethyl acetate extract of Pleurotus giganteus was 2.26%, 10.58% 
and 50.28%, respectively. Amongst the unsaturated fatty esters, methyl linoleate was 
the predominant fatty ester in Pleurotus giganteus forming 50.28% of the total ethyl 
acetate extract. Further fractionation of the crude ethyl acetate extract allowed identifi-
cation of methyl mandelate and palmitic acid from the PGF9 subfraction. The composi-
tion of methyl mandelate and palmitic acid contributed 11.69% and 53.59% respectively 
of the PGF9 subfraction. In subfraction PGHEX4 palmitic acid was also identified and 
represented 10.19% of the subfraction. Palmitic acid is the first fatty acid produced dur-
ing lipogenesis (fatty acid synthesis) and from which longer fatty acids can be pro-
duced. In PGF10 subfraction myristic acid was identified and its composition was 
20.98%.In the hexane extract of Pleurotus giganteus, oleic acid was identified in the 
PGHEX5 and PGF37 subfractions. The composition of this fatty acid in the subfractions 
was 68.05% and 95.55% and is as a monounsaturated omega-9 fatty acid. Oleic acid has 
been reported to reduce coronary heart disease risk by 20–40% mainly via LDL-
cholesterol reduction (Lopez-Huertas, 2010). As intakes of saturated fat in many coun-
tries are higher that the recommended levels, an increase in the intake of oleic acid may 
be beneficial as it limits the intake of saturated fat (Lopez-Huertas, 2010).  
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5.2 Phenolic Compounds 
Natural phenolics are compounds possessing one or more aromatic rings with one or 
more hydroxyl groups and can range from simple molecules (phenolic acids, phe-
nylpropanoids, flavonoids) to highly polymerised compounds (lignins, melanins, tan-
nins). Particularly, phenolic acids can be subdivided into two major groups, hy-
droxybenzoic acids and hydroxycinnamic acids. Hydroxybenzoic acids include p-
hydroxybenzoic, protocatechuic, vanillic, syringic, and gallic acids. They are commonly 
present in the bound form and are typically a component of a complex structure like 
lignins and hydrolyzable tannins. They can also be found linked to sugar derivatives and 
organic acids in plant foods. Hydroxycinnamic acids include p-coumaric, caffeic, feru-
lic, and sinapic acids. In natural sources they are mainly found esterified with small 
molecules like, e.g., quinic or tartaric acids, as well as bound to cell-wall structural 
components such as cellulose, lignin, and proteins through ester bonds (Barros et al., 
2009).  
In this study, nine phenolic compounds were identified in Pleurotus giganteus. 
In PGF9 subfraction of the ethyl acetate extract p-tert-butylphenol and 2, 5-bis (1, 1-
dimethylethyl) phenol were identified and amounted to 0.62% and 0.90% of the sub-
fraction. Methyl vanillin was also identified in the ethyl acetate subfraction (PGF39) 
and amounted to 12.96% of the fraction. In the hexane extract subfraction (PGHEX19) 
4 –hydroxyl benzeneethanol was identified and amounted to 0.84% of the fraction. 
Coumaric acid, cinnamic acid, benzoic acid and caffeic acid comprising of 0.07%, 
0.10%, 2.14% and 1.31% respectively.They have been previously identified in fungi      
( Ribeiro et al., 2007, Kanagasabapathy et al., 2011, Ferreira et al., 2009). 
Hydroxybenzoicacid was identified in the butanol extract and represented 0.67% of the 
extract. 
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Cinnamic acid and its amides, esters and other derivatives are important but un-
der utilized class of compounds. As anticancer agents they are cytotoxic, cytostatic, 
antiproliferative, antiangeogenetic, antileukemic, active against solid tumors, inhibit 
different enzymes e.g. transglutaminase, aminopeptidase N, histone deacetylase etc, 
cause DNA-damage and many more. In spite of all these multi-activities of cinnamic 
acid derivatives their mode of action and understanding of molecular mechanisms re-
mains unclear (Del et al., 2010). In animal experiment eugenol and cinnamic acid inhib-
ited HCL/ethanol induced gastric lesions and increased the mucus content. It is suggest-
ed they are useful neutraceuticals for gastritis (Jung et al., 2011). 
Coumaric acid and caffeic acid have also exhibited antioxidant activity (Cuvelier 
et al., 1992). Tyrosol was for the first time identified in fungi during this study. As an 
antioxidant, tyrosol (4 –hydroxyl, benzeneethanol) can protect cells against injury due 
to oxidation. Although it is not as potent as other antioxidants present in olive oil, its 
higher concentration and good bioavailability indicate that it may have an important 
overall effect. This effect may contribute significantly to the health benefits of olive oil 
and, more generally, the diet. Tyrosol present in white wine is also shown to be cardio-
protective (Giovannini et al., 1999). Samuel et al., (2008) have shown that tyrosol-
treated animals showed significant increase in the phosphorylation of Akt, eNOS and 
FOXO3a. In addition, tyrosol also induced the expression of longevity protein SIRT1 in 
the heart after myocardial infarction in a rat MI model (Samuel et al., 2008). In conclu-
sion these findings suggest that tyrosol induces myocardial protection against ischemia 
related stress by inducing survival and longevity proteins that may be considered as 
anti-aging therapy for the heart.  
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5.3 Sterols 
Even though mushrooms are deficient in vitamin D2, earlier researchers have found 
them to be rich source of ergosterol. In this study the percentage of ergosterol present in 
the ethyl acetate subfraction (PGF10) of Pleurotus giganteus was 20.44 %. Many re-
ports have revealed that ergosterol acts as a biological precursor to vitamin D2. It is 
turned into viosterol by ultraviolet light, temperature of irradiation and moisture content 
and is then converted into ergocalciferol, which is a form of Vitamin D2  (Jasinghe & 
Perera, 2007) used for pharmaceutical applications and food supplements. Ergosterol is 
a component of fungal cell membranes, serving the same function as cholesterol in ani-
mal cells. Ergosterol is the principal sterol and is present in two forms, as free ergosterol 
and esterified ergosterol. Ergosterol and one of its isomers were reported in this investi-
gation. The isomer of ergosterol that was identified was neoergosterol, also found in 
fraction PGF10. These compounds present the characteristic template of tetracyclic 
triterpenes, mostly sterols, with structural characteristics that vary in number and posi-
tion of the unsaturation’s in the rings and in the side chains, and in the keto and hydrox-
yl groups located in different positions of the triterpenic template. Kuo et al. (2011) 
reported that ergosterol was able to inhibit LPS-induced inflammation in RAW 264.7 
marophages by suppressing the NF-κB signaling pathway. Some other mushrooms in 
which ergosterol has been identified are Japanese edible mushroom ‘Buna-shimeji’, 
(Hypsizigus marmoreus), ‘white button (Agaricus bisporus), enoki (Flammulina ve-
luptipes), shiitake (Lentinus edodes), maitake (Grifola frondosa), oyster (Pleurotus os-
treatus), crimini (Agaricus bisporus) and portabella (Agaricus bisporus) (Yasukawa et 
al., 1994 & Phillips et al., 2011). 
Campesterol is a phytosterol which the chemical structure is similar to that of 
cholesterol. Campesterol was the minor component in Pleurotus giganteus. In this study 
the percentage of campesterol present in the hexane subfraction (PGHEX9) of Pleurotus 
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giganteus was 0.95 %. Many vegetables, fruits, nuts and seeds contain campesterol, but 
in low concentrations. Banana, pomegranate, pepper, coffee, grapefruit, cucumber, on-
ion, oat, potato and lemon grass (citronella) are few examples of common sources con-
taining campesterol at 1-7 mg/100 mg of the edible portion. In contrast, canola and corn 
contain 50-200 mg of campsterol (Seguraa et al., 2006). It is so named because it was 
first isolated from the rapeseed (Brassica campestris). It is known to have cholesterol-
lowering activity (Seguraa et al., 2006) and anti-inflammatory effect (Gabay et al., 
2010). It was reported to inhibit several pro-inflammatory and matrix degradation medi-
ators typically involved in osteoarthritis-induced cartilage degradation (Gabay et al., 
2010). Campesterol has been previously identified in ‘morel’ Morchella spp of mush-
room (Phillips et al., 2011). 
 
5.4 Succinic Acid 
Succinic acid was identified in the aqueous extract and amounted to 12.57% of the ex-
tract. Succinic acid is a dicarboxylic acid and plays a biochemical role in the citric acid 
cycle. The name derives from Latin succinum, meaning amber, from which the acid 
may be obtained. The carboxylate anion is called succinate and esters of succinic acid 
are called alkyl succinates. Succinic acid has been previously identified in mushrooms 
(Valentao et al., 2005). In the study conducted by Valentao et al. (2005), six species of 
wild edible mushrooms were studied, namely Amanita caesarea, Boletus edulis, Gyro-
porus castaneus, Lactarius deliciosus, Suillus collinitus, and Xerocomus chrysenteron. 
Succinic acid was present in very small amounts, below 0.2% of the total quantified 
compounds in all the tested species (Valentao et al., 2005). 
The inhibition of lipid peroxidation by idebenone in brain mitochondria in the 
presence of succinate is the process whereby free radicals “steal” electrons from the 
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lipids in our cell membranes, resulting in cell damage and increased production of free 
radicals. Lipid peroxidation in brain mitochondria was induced by NADH in the pres-
ence of ADP and FeCl3. A novel quinone compound, idebenone, inhibited this peroxi-
dation and the inhibition was markedly enhanced by succinate, a substrate of mitochon-
drial respiration (Suno & Nagaoka, 1989). The concentration of succinate required to 
exert the maximal effect was 1.5 mM. The concentration of idebenone giving 50% inhi-
bition  was 0.5 and 84mM in the presence and absence of succinate, respectively, indi-
cating that succinate enhances the inhibition by 170-fold. These results indicate that 
idebenone is changed to its reduced form, which protects mitochondria against lipid 
peroxidation (Suno & Nagaoka, 1989). 
The life-extending gene Indy encodes an exchanger for Krebs-cycle intermedi-
ates. A longevity gene called Indy, with homology to mammalian genes encoding Na-
dicarboxylate cotransporters, was identified in Drosophila melanogaster. Efflux of 
[14C]-citrate from INDY-expressing oocytes was greatly accelerated by the addition of 
succinate to the external medium, indicating citrate-succinate exchange. From the study 
it concluded that INDY functions as an exchanger of dicarboxylic and tricarboxylic 
Krebs cycle intermediates. The effect of decreasing INDY activity, as in the long- lived 
Indy mutants, may be to alter energy metabolism in a manner that favours life span ex-
tension (Knauf et al., 2006). 
Cardioprotective effect of succinate is protective against ischemia/reperfusion 
injury (Sakamoto et al., 1998). In another study, it was investigated the protective ef-
fects of succinate, which is a respiratory substrate and a potential antioxidant, on myo-
cardial ischemia/reperfusion injury with the whole heart. Isolated rat hearts were loaded 
with 25-min normothermic global ischemia followed by 30- min reperfusion in a work-
ing heart model. Succinate administered either before reperfusion or added to the cardi-
oplegic solution improved the postischemic cardiac function significantly. The hearts 
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arrested with succinate-supplemented cardioplegic solution replenished high-energy 
phosphates and maintained the total adenine nucleotides during the reperfusion period, 
whereas those arrested with succinate-nonsupplemented cardioplegic solution replen-
ished the high-energy phosphates less, and also lost total adenine nucleotides during that 
period. It was concluded that succinate administered before reperfusion may decrease 
the degree of mitochondrial damage during reperfusion and thereby reduce the amount 
of myocardial ischemia/reperfusion injury. Postischemic administration of succinate 
reverses the impairment of oxidative phosphorylation after cardiac ischemia and reper-
fusion injury (Sakamoto et al., 1998). 
 
5.5 Nicotinamide 
Nicotinamide which was identified in the subfraction (PGF37) represented 1.07% of the 
extract. In a previous study on Pleurotus sajor caju mushroom, nicotinamide was iden-
tified (Kanagasabapathy et al., 2011). Nicotinamide, also known as niacinamide and 
nicotinic acid amide, is the amide of nicotinic acid (vitamin B3 / niacin). Nicotinic acid 
is converted to nicotinamide and the two are identical in their vitamin functions. Inves-
tigations on the medicinal properties of nicotinamide have been studied for more than a 
decade.  Nicotinamide was reported to inhibit lipid peroxidation in rat brain mitochon-
dria. It is stated that, the percentage of lipid peroxidation inhibition displayed by nico-
tinamide is comparable to tryptophan and isonicotinic acid and higher than ascorbic 
acid. This is due to the amide group in nicotinamide that plays an important role as O2 
and other reactive species quenchers (Kamat & Devasagayam, 1999). Hence nicotina-
mide can be considered as a potent antioxidant capable of protecting the cellular mem-
branes in brain, which is highly susceptible to pro-oxidants, against oxidative damage 
induced by ROS.  
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5.6 Uridine 
Uridine which was identified in the aqueous fraction represented 0.55% of the extract. 
Uridine is one of the four basic components of ribonucleic acid (RNA); the other three 
are adenosine, guanosine, and cytidine. The bioavailability of uridine is particularly 
crucial to the synthesis of RNA and biomembranes via the formation of pyrimidine nu-
cleotideÐlipid conjugates, and thus is essential for cellular function and growth. Clinical 
trials involving therapeutic doses of uridine and its nucleotides are being investigated to 
treat dieses such hereditary orotic aciduria, cystic fibrosis, liver dysfunction, cancer, 
schizophrenia and epilepsy (Connolly & Duley, 1999). 
 
5.7 Alkaloid 
Phenylethylamine alkaloids are  aromatic amine made up of a benzene ring to which an 
ethylamine side chain is attached . The phenylethylamine alkaloid group is a precursor 
of many natural and synthetic compounds. Several substituted phenylethylamine 
alkaloid group are pharmacologically active compounds found in plants and animals. 
This group includes simple phenylamine (tyramine, hordenine) and catecholamine 
(dopamine). The latter was found in animals and terrestrial plants (Barroso & Rodri-
guez., 1996). The structure of phenylethylamine alkaloid group allows substitutions on 
the aromatic ring, the α and β carbons and terminal amino group. N-
acetylphenylethylamine which is a phenylethylamine alkaloid, was identified in the 
hexane extract (PGHEX16). It represented 5.07% of the fraction. This is the first time 
N-acetylphenylethylamine was identified in mushrooms. In a previous study N-
acetylphenylethylamine was isolated from the red algae Phyllophora crispa and Gelidi-
um crinale. They exhibited pharmacological activity on the nigrostriatal dopamine neu-
rotransmission (Barroso & Rodriguez., 1996). 
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5.8 Benzyl alcohol 
Benzyl alcohol was identified in the essential oil extract and it represented 1.01% of the 
fraction. It was also identified in other mushrooms for example Agaricus bisporus 
(Espín & Wichers., 1999). Benzyl alcohol is a fragrance ingredient used in many com-
pounds. It may be found in fragrances used in decorative cosmetics, fine fragrances, 
shampoos, toilet soaps and other toiletries as well as in non-cosmetic products such as 
household cleaners and detergents. It is a colourless liquid with a faint, nondescript 
odour, rather sweet, but varies considerably with the quality of the alcohol. This materi-
al has been reported to occur in nature, with highest quantities observed in species of 
allium plants (Scognamiglio et al., 2011). 
 
5.9 Recommendations for further studies 
As a large number of compounds were detected but unidentified, further work can per-
formed on the characterization/identifaction of these compounds which could lead to 
new interesting and potentially previously undiscovered compounds. These compounds 
can open up new avenues of research. 
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CHAPTER 6 
CONCLUSION 
 
In this study, the compounds isolated from Pleurotus giganteus identified by GC-MS or 
LC/MS/MS. Various types of extraction methods were applied in this investigation 
because different compounds are extracted by different solvents based on the solvent’s 
polarity. The solvents employed in the present study were methanol, hexane, ethyl 
acetate, distilled water and butanol. The  ethyl acetate and hexane extracts  were then 
subjected to  flash column chromatography with stepwise addition of hexane and 
acetone. Finally the identification of compounds in the sub-fractions from ethyl acetate 
and hexane were done using  GC-MS and LC-MS/MS analyses. Extraction of the 
flavour components (essential oil) was performed. Compounds such as benzyl alcohol 
were identified in this extract.  
 Twenty six compounds were identified from the fruiting bodies of Pleurotus 
giganteus. The secondary metabolites were fatty acids such as palmitic acid and oleic 
acid; fatty acids methyl esters such as methyl linoleate; phenolics such as caffeic acid 
and cinnamic acid; sterols such as ergosterol and neoergosterol;  organic acids such as 
succinic acid and alkaloids such as N-acetylphenylethylamine. 
Phenolic compounds were the most abundant compounds identified. Phenolic 
compounds such as benzoic acid, coumaric acid, cinnamic acid and caffeic were identi-
fied in the aqueous extract. This was due to phenolic compounds tend to be water-
soluble. Other phenolic compounds were also identified in the hexane and the ethyl ace-
tate such as 4-tert-butylphenol. Fatty acids such oleic acid were the predominant fatty 
acids identified in Pleurotus giganteus. 
 The compounds identified in Pleurotus giganteus possess medicinal properties 
and have been reported in many scientific literatures. Individually and through syner-
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gism these compounds can potentially provide health benefits. Pleurotus giganteus has 
a high potential to be produced economically on a large scale in Malaysia. The 
nutraceutical value of this mushroom should be emphasized to increase the mushroom 
intake in daily diet. By doing so, the popularity of Pleurotus giganteus could eventually 
grow and be comparable to other popular edible or medicinal mushrooms such as Tuber 
sp. (truffles) and G. Lucidum (ling-zhi). However further study validating the finding of 
this thesis need to be performed. This would include isolating the identified compounds 
so characterization of potentially bioactive activity could be compared to previous work 
carried out in research literature.  
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